News
- Author:
- Sharon Worcester, MA
Publish date: October 6, 2023
“ASH continues to support the importance of lifelong learning for hematologists via a program that is evidence-based, relevant to one’s practice, a...
News
- Author:
- Sharon Worcester, MA
Publish date: October 5, 2023
“These new survey results remind us that we are still in an ongoing crisis and must respond with appropriate urgency.”
News
- Author:
- Sharon Worcester, MA
Publish date: October 3, 2023
The APRT role helps reduce physician burnout and optimize patient experience.
News
- Author:
- Sharon Worcester, MA
Publish date: September 19, 2023
A first-degree family history confers higher cancer risk, thus family history should be taken into consideration to limit exposing lower-risk patie...
News
- Author:
- Sharon Worcester, MA
Publish date: September 15, 2023
Various guidelines that address physicians' role in patient awareness and knowledge focus on assessing patient needs and readiness to learn, commun...
News
- Author:
- Sharon Worcester, MA
Publish date: August 29, 2023
The findings “may help health professionals to alleviate feelings of guilt and self-blame in patients with cancer who attribute their diagnosis to ...
News
- Author:
- Sharon Worcester, MA
Publish date: August 15, 2023
While the FDA says it “shares concerns about the release of ethylene oxide at unsafe levels into the environment,” the agency cautions that mo...
News
- Author:
- Sharon Worcester, MA
Publish date: August 15, 2023
The findings could help in developing specific guidelines related to the prevention of breast cancer recurrence and death in survivors.
News
- Author:
- Sharon Worcester, MA
Publish date: August 15, 2023
Elranatamab previously received Breakthrough Therapy Designation for relapsed or refractory multiple myeloma.
News
- Author:
- Sharon Worcester, MA
Publish date: August 14, 2023
This new agent "brings an important treatment option to patients with prostate cancer as they consider their road ahead."
News
- Author:
- Sharon Worcester, MA
Publish date: August 10, 2023
Accelerated approval has been granted by the FDA to talquetamab-tgvs, a bispecific antibody, for patients with myeloma who have undergone at least ...
News
- Author:
- Sharon Worcester, MA
Publish date: August 4, 2023
The potential for overdiagnosis or overdetection of indolent lesions in the intervention group should “prompt caution in the interpretation of resu...
News
- Author:
- Sharon Worcester, MA
Publish date: August 2, 2023
“It’s a pain-in-the-ass module that you sit at home and Google – it’s not really any sort of assessment,” nor does it help protect the public.
News
- Author:
- Sharon Worcester, MA
Publish date: July 18, 2023
“One concern is that over the last 10 years or so, most of our new treatments have had very, very small benefits and we think the bar has dropped t...
News
- Author:
- Sharon Worcester, MA
Publish date: July 14, 2023
“In short the evidence that aspartame causes primary liver cancer, or any other cancer in humans, is very weak.”
